Testosterone replacement therapy in older adult men
Author:
Open Access
- 1 October 1999
- journal article
- review article
- Published by Wiley in International Journal of Andrology
- Vol. 22 (5) , 300-306
Abstract
Serum testosterone levels decline slowly with normal ageing in men and, although all men are not destined to become hypogonadal as they age, the prevalence of androgen deficiency in the older male is not insignificant. Over the past several decades, there has been an increasing interest in evaluating whether testosterone therapy (male HRT) might be beneficial for certain older men in preventing or reversing some aspects of ageing. The major androgen target organs of interest with regard to beneficial effects of male HRT include bone, muscle, adipose tissue, the cardiovascular system and the central nervous system (libido and aspects of mood). At the same time, potential adverse effects of male HRT on target organs such as the prostate continue to be evaluated. It is the purpose of this review to summarize the information to date with regard to testosterone replacement therapy in the older man and to discuss areas where more research and clinical information need to be forthcoming.Hormonal replacement therapy (HRT) for post‐menopausal women has been studied and discussed for many years. The idea of male HRT, however, is a relatively recent development, with increasing interest in this area occurring only over the past two decades. Reasons for this nascent enthusiasm include burgeoning evidence that testosterone levels decline with normal male ageing (and with age‐associated diseases) and an interest in preventing age‐related dysfunction and prolonging quality life among an ever increasing population of older adults. The decline in testosterone with age often parallels unfavourable changes in organs upon which androgens act and the goal of male HRT would be to prevent, stabilize or even reverse some of these detrimental target‐organ changes.Keywords
This publication has 34 references indexed in Scilit:
- Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable EstrogenThe Journal of Clinical Endocrinology & Metabolism, 1998
- Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 1997
- Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadismThe Journal of Clinical Endocrinology & Metabolism, 1996
- Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrateThe Journal of Clinical Endocrinology & Metabolism, 1995
- Androgen and progestagen effects on plasma lipidsProgress in Cardiovascular Diseases, 1995
- Androgen Treatment of Abdominally Obese MenObesity Research, 1993
- Effects of testosterone supplementation in the aging maleThe Journal of Clinical Endocrinology & Metabolism, 1992
- REVERSIBLE REPRODUCTIVE DYSFUNCTION IN MEN WITH OBSTRUCTIVE SLEEP APNOEAClinical Endocrinology, 1988
- Testosterone Therapy for Low Sexual Interest and Erectile Dysfunction in Men: a Controlled StudyThe British Journal of Psychiatry, 1984
- Obstructive Sleep Apnea Syndrome Induced by Testosterone AdministrationNew England Journal of Medicine, 1983